Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,212.3
-1.7 (-0.05%)

 

  • STI Straits Times Index
    3,212.3
    -1.7 (-0.05%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,573.2
    2.1 (0.13%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,508.1
    -179.7 (-0.65%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,984.4
    16.7 (0.56%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,952.3
    -70.8 (-0.29%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,215.4
    18.1 (0.29%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,168.2
    -2.1 (-0.10%)
    Index delayed 20 minutes
  • XAO XAO
    6,952.3
    107.7 (1.57%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 592.0M
  • Value: 562.6M
  • Rise: 139
  • Fall: 153
  • Unch: 534

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.186-
SunMoonFood^0.051+0.011
TEE Intl0.058+0.003
YZJ Shipbldg SGD1.090-0.040
Golden Agri-Res0.215-0.005
Interra Resource^0.065+0.004
Tritech0.024-
Singapore-eDev0.045+0.005
AusGroup^0.032-0.001
JCG Investment0.002-

World Indices

World Indices
Name Last Change
Nasdaq 8,734.9 +17.6
HSI 27,508.1 -179.7
HSCEI 10,778.9 -59.2
Jakarta 6,215.0 +17.7
Nikkei 225 23,952.3 -70.8
SSE Comp 2,984.4 +16.7
Shanghai A 3,127.2 +17.5
Shanghai B 247.1 +1.2
PSE Comp 0.0
KOSPI 2,168.2 -2.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Biolidics BIOLIDICS LIMITED
Quotes 10 Minutes Delayed. Updated at 16 Dec 2019 15:10
Last (SGD): 0.250 Change: -0.010 High: 0.250 Remarks: -
Change (%): -3.85 Low: 0.245
Open 0.250 Yesterday's Close 0.260
Buy Price 0.245 Sell Price 0.250
Buy Volume ('000) 5.5 Sell Volume ('000) 6.2
Cumulative Volume ('000) 61.5 Cumulative Value 15,325
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.02578 Trailing EPS (SGD) e -0.02578 NAV (SGD) b 0.0445
PE a - Trailing PE f - Price / NAV b 5.6180
Dividend (SGD) d - Cash In Hand (SGD) g 0.0374 Issued & Paid-up Shares c 242,500,000
Dividend Yield (%) d - Price / Cash In Hand g 6.684 Treasury Shares h -
Beta - 75 Daysi -0.175 R-Squared - 75 Days(%)i 0.22 Market Cap (M) 60.625
Beta - 500 Daysi 0.858 R-Squared - 500 Days (%)i 2.53 Enterprise Value (M) 51.655
Piotroski F Score - Exchange Code 8YY Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 6-Month VWAP 0.256 Free Float (%) 99.6
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Prof, Scientific & Technical Activities - Medical Specialties
Category Classification Medical & Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Biolidics SGX 60.625 - - 5.6180 -
Industry Medical & Biotechnology SGX 992.265 22.599 23.385 1.3831 1.878
Medical Specialties SGX 650.974 38.067 38.251 3.9471 0.875
Local Peer Top Glove SGX 3,738.460 30.672 30.674 4.6855 0.901
Local Peer Yunnan Energy SGX 43.794 - - 0.8923 -
Local Peer UG Healthcare SGX 27.062 10.794 15.255 0.6440 1.850
Local Peer Medtecs Intl SGX 19.229 15.419 14.953 0.2261 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 152,614.990 64.860 46.657 4.7966 1.334
Global Peer MEDTRONIC PLC NYSE 152,159.938 32.857 32.589 3.0084 1.833
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 128,517.615 43.743 35.779 4.3781 0.228
Global Peer DANAHER CORP NYSE 106,679.094 40.243 43.881 3.4521 0.421
Global Peer STRYKER CORP NYSE 75,976.992 21.384 22.177 6.1695 0.951
Global Peer BECTON DICKINSON & CO NYSE 72,678.011 - - - -
Global Peer INTUITIVE SURGICAL INC NASDAQ 66,992.469 59.396 50.980 8.6315 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 62,847.344 37.611 57.658 6.4798 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 48,521.725 67.186 62.714 12.7193 -
Global Peer BAXTER INTERNATIONAL INC NYSE 42,866.282 26.395 27.096 5.4872 0.874
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), WATERS CORP (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), HOLOGIC INC (NASDAQ), STERIS PLC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), DENTSPLY SIRONA INC (NASDAQ), INSULET CORPORATION (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), NOVOCURE LTD (NASDAQ), BRUKER CORPORATION (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), PENUMBRA INC (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), WEIGAO GROUP (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), HARTA (Bursa), NUVASIVE INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), LIVANOVA PLC (NASDAQ), ICU MEDICAL INC (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), CANTEL MEDICAL CORP (NYSE), CONMED CORP (NASDAQ), QUIDEL CORP (NASDAQ), TOPGLOV (Bursa), GLAUKOS CORPORATION (NYSE), EBOS GROUP (ASX), INSPIRE MEDICAL SYSTEMS INC (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), MICROPORT (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), AVANOS MEDICAL INC (NYSE), INOGEN INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), NANOSONICS LIMITED (ASX), ATRION CORP (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), INMODE LTD (NASDAQ), ATRICURE INC (NASDAQ), AK MEDICAL (HKEx), VAREX IMAGING CORPORATION (NASDAQ), MESA LABORATORIES INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), CAREDX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), VENUS MEDTECH-B (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), CIRC (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), VERICEL CORP (NASDAQ), ANTARES PHARMA INC (NASDAQ), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LIFETECH SCI (HKEx), LEMAITRE VASCULAR INC (NASDAQ), QUOTIENT LTD (NASDAQ), AXOGEN INC (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CERUS CORP (NASDAQ), SURMODICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), CUTERA INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SI BONE INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), SUPERMX (Bursa), SIENTRA INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), YESTAR HEALTH (HKEx), ALPHATEC HLDGS INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), CORMEDIX INC (NYSE American), INFUSYSTEM HOLDINGS INC (NYSE American), BIOLIFE SOLUTIONS INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), INVACARE CORP (NYSE), STEREOTAXIS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), ZYNEX INC (NASDAQ), PW MEDTECH (HKEx), GOLDEN MEDITECH (HKEx), IRADIMED CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MISONIX INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), CRH MEDICAL CORP (NYSE American), VAPOTHERM INC (NYSE), REPRO MEDSYSTEMS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), KDL MEDICAL (HKEx), RTI SURGICAL HOLDINGS INC (NASDAQ), MODERN DENTAL (HKEx), SOLITON INC (NASDAQ), INTRICOM CORP (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), DERMTECH INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), FONAR CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), MY MEDICARE (HKEx), TELA BIO INC (NASDAQ), SOMNOMED LIMITED (ASX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), PROFOUND MED CORP (NASDAQ), CONFORMIS INC (NASDAQ), YUNNAN ENERGY (HKEx), COMPUMEDICS (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), NEURONETICS INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), SDI LTD (ASX), ONCOCYTE CORP (NYSE American), ELECTROMED INC (NYSE American), MOTUS GI HOLDINGS INC (NASDAQ), NEPHROS INC (NASDAQ), IMPEDIMED LIMITED (ASX), RESONANCE HEALTH LTD (ASX), MRI INTERVENTIONS INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), ELLEX MEDICAL LASERS LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), KELFRED (HKEx), ALPHA PRO TECH (NYSE American), OVENTUS MEDICAL LTD (ASX), CYCLOPHARM LIMITED (ASX), VINCENT MED (HKEx), MILESTONE SCIENTIFIC INC (NYSE American), ELECTROCORE INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), EKSO BIONICS HOLDINGS INC (NASDAQ), ENDOLOGIX INC (NASDAQ), DAXOR CORP (NYSE American), IMMUCELL CORP (NASDAQ), CELSION CORPORATION (NASDAQ), RESPIRI LTD (ASX), PAVMED INC (NASDAQ), ADMEDUS LTD (ASX), IRIDEX CORP (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), BIOMERICA INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), MICRO-X LTD (ASX), NEOVASC INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), ADVENTA (Bursa), LIFE HEALTHCARE (HKEx), OBJ LIMITED (ASX), REWALK ROBOTICS LTD (NASDAQ), DIMERIX LTD (ASX), BIOLASE INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), CARDIEX LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DARIOHEALTH CORP (NASDAQ), CYANOTECH CORP (NASDAQ), ATOSSA GENETICS INC (NASDAQ), AVINGER INC (NASDAQ), LKL (Bursa), OPTISCAN IMAGING (ASX), CHECK-CAP LTD (NASDAQ), USCOM LTD (ASX), COMBEST HOLD (HKEx), PREDICTIVE ONCOLOGY INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), NEUROTROPE INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), LIANLUO SMART LIMITED (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), MICRON SOLUTIONS INC (NYSE American), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), INSPIREMD INC (NYSE American), DYNATRONICS CORP (NASDAQ), DIGIRAD CORP (NASDAQ), CH DEMETER FIN (HKEx), STHAI (SET), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), MEDIGARD LIMITED (ASX), METALICITY LIMITED (ASX), AKERS BIOSCIENCES INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days --0.015
-5.66 %
20 Days --0.015
-5.66 %
Medium Term Return 3 Months --0.010
-3.85 %
6 Months --0.040
-13.79 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.180 - 0.330 Change From 1 Year Low +0.070 % Change From 1 Year Low (%) +38.89
Change From 1 Year High -0.080 % Change From 1 Year High (%) -24.24
2 Years Range 0.180 - 0.330 Change From 2 Years Low +0.070 % Change From 2 Years Low (%) +38.89
Change From 2 Years High -0.080 % Change From 2 Years High (%) -24.24
5 Years Range 0.180 - 0.330 Change From 5 Years Low +0.070 % Change From 5 Years Low (%) +38.89
Change From 5 Years High -0.080 % Change From 5 Years High (%) -24.24
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide.The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

IPO Performance

Listing Date 19 Dec 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 27.50 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.235 First Week Close (SGD) 0.230
Current vs IPO Price (%) -10.71 First Day Gain (%) -16.07 First Week Gain (%) -17.86

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(3.41 MB)
IPO Prospectus
IPO Prospectus 2018 Dec 2018 Part 1(2.88 MB)
Part 2(0.53 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
13 Dec 2019 0.250 0.260 0.250 0.260 56,700 0.2504
12 Dec 2019 0.260 0.260 0.260 0.260 - -
11 Dec 2019 0.260 0.260 0.260 0.260 - -
10 Dec 2019 0.260 0.260 0.260 0.260 - -
09 Dec 2019 0.260 0.260 0.250 0.260 24,500 0.2504
06 Dec 2019 0.255 0.255 0.250 0.250 31,500 0.2532
05 Dec 2019 0.255 0.255 0.255 0.255 - -
04 Dec 2019 0.255 0.255 0.255 0.255 5,000 0.2550
03 Dec 2019 0.255 0.255 0.250 0.255 50,000 0.2530
02 Dec 2019 0.265 0.265 0.265 0.265 - -
29 Nov 2019 0.265 0.265 0.265 0.265 - -
28 Nov 2019 0.260 0.265 0.260 0.265 139,500 0.2600
27 Nov 2019 0.265 0.270 0.265 0.270 219,700 0.2658
26 Nov 2019 0.265 0.270 0.260 0.265 144,000 0.2639
25 Nov 2019 0.260 0.260 0.260 0.260 - -
22 Nov 2019 0.260 0.260 0.260 0.260 4,200 0.2600
21 Nov 2019 0.260 0.270 0.260 0.270 392,000 0.2662
20 Nov 2019 0.265 0.265 0.265 0.265 - -
19 Nov 2019 0.260 0.280 0.260 0.265 209,600 0.2649
18 Nov 2019 0.265 0.265 0.265 0.265 - -
15 Nov 2019 0.265 0.265 0.265 0.265 13,500 0.2650
14 Nov 2019 0.260 0.275 0.260 0.275 80,800 0.2666
Summary
Current 2 Weeks
(02 Dec 2019 to 13 Dec 2019)
0.265 0.265 0.250 0.260 167,700 -
Previous 2 Weeks
(18 Nov 2019 to 29 Nov 2019)
0.265 0.265 0.250 0.265 1,109,000 -
4 Weeks from
(18 Oct 2019 to 15 Nov 2019)
0.225 0.265 0.225 0.265 1,206,100 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.